Research information only. Not medical advice. 18+ only. Not FDA-approved for human therapeutic use.

Humanin vs SS-31

Comparison

Humanin and SS-31 are two peptides people frequently compare. Humanin is a small peptide the body makes naturally, mostly in brain and nerve cells. Researchers are studying it as a possible protector of brain and heart cells, and as a biomarker for Alzheimer's,… SS-31 (elamipretide) is a synthetic peptide studied for protecting mitochondria — the energy generators in cells — from damage in diseases like heart failure, kidney injury, and rare mitochondrial…

Humanin SS-31
What it is Humanin is a small peptide the body makes naturally, mostly in brain and nerve cells. Researchers are studying it as a possible protector of brain and heart cells, and as a biomarker for Alzheimer's,… SS-31 (elamipretide) is a synthetic peptide studied for protecting mitochondria — the energy generators in cells — from damage in diseases like heart failure, kidney injury, and rare mitochondrial…
Primary uses
  • Alzheimer's disease (neuroprotection, biomarker, therapeutic candidate)
  • Cardiovascular disease (biomarker and cardioprotection)
  • Diabetes (type 1, type 2, gestational) and metabolic disorders
  • Diabetic nephropathy (renal protection)
  • Acute kidney injury (AKI) — cisplatin-induced and rhabdomyolysis-associated
  • Heart failure / cardiac dysfunction
  • Barth syndrome (tafazzin deficiency / cardiolipin remodeling disorder)
  • Friedreich ataxia
How it works Researchers are studying it as a possible protector of brain and heart cells, and as a biomarker for Alzheimer's, diabetes, and age-related decline. No FDA-approved use yet; the research is still at… It works by binding to a key mitochondrial membrane component and reducing oxidative damage. Not FDA-approved for commercial use; active Phase 2/3 trials ongoing.
Common dose 2 mg, subcutaneous injection, 3x per week 2 mg, subcutaneous injection, daily
FDA status Not stated in reviewed literature — requires manual verification Not stated in reviewed literature — requires manual verification. Abstract PMID 41966639 characterizes SS-31 among peptides operating in a 'gray market' of unapproved compounds marketed direct to…
Evidence level Human observational Human observational